Investment Focus

MPH invests in seed to late-stage lifesciences companies based principally in North America and Europe, usually as part of an investment syndicate with other leading VC firms.

Technology Focus

MPH invests in companies developing novel therapeutics (small molecule and biotherapeutics), technology platforms, diagnostics and vaccines.

Therapeutic Focus

MPH is interested in novel drugs and diagnostics in various disease areas, including:

  • Nephrology
  • Immunology and Inflammation
  • Cardiovascular
  • Neuroscience
  • Stroke
  • Metabolic disease